At baseline and at weeks 8 and 12, a clinician should assess fasting insulin and HOMA-IR (the homeostasis model assessment of insulin resistance, a calculated index derived from fasting glucose and insulin), HbA1c, high-sensitivity C-reactive protein as an inflammatory marker, and body composition by DEXA scan or bioelectrical impedance
Aging (Albany NY) 12 (22), 2244522456
In some cases, independent testing has revealed contaminants, degraded compounds, or dosages that are significantly higher or lower than advertised
We know about these interactions because Novo Nordisk, the manufacturer of FDA-approved Wegovy, Ozempic, and Rybelsus, is required to report adverse events to the FDA